» Articles » PMID: 23275610

Postprandial Gut Hormone Responses and Glucose Metabolism in Cholecystectomized Patients

Overview
Date 2013 Jan 1
PMID 23275610
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Preclinical studies suggest that gallbladder emptying, via bile acid-induced activation of the G protein-coupled receptor TGR5 in intestinal L cells, may play a significant role in the secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) and, hence, postprandial glucose homeostasis. We examined the secretion of gut hormones in cholecystectomized subjects to test the hypothesis that gallbladder emptying potentiates postprandial release of GLP-1. Ten cholecystectomized subjects and 10 healthy, age-, gender-, and body mass index-matched control subjects received a standardized fat-rich liquid meal (2,200 kJ). Basal and postprandial plasma concentrations of glucose, insulin, C-peptide, glucagon, GLP-1, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-2 (GLP-2), cholecystokinin (CCK), and gastrin were measured. Furthermore, gastric emptying and duodenal and serum bile acids were measured. We found similar basal glucose concentrations in the two groups, whereas cholecystectomized subjects had elevated postprandial glucose excursions. Cholecystectomized subjects had reduced postprandial concentrations of duodenal bile acids, but preserved postprandial plasma GLP-1 responses, compared with control subjects. Also, cholecystectomized patients exhibited augmented fasting glucagon. Basal plasma CCK concentrations were lower and peak concentrations were higher in cholecystectomized patients. The concentrations of GIP, GLP-2, and gastrin were similar in the two groups. In conclusion, cholecystectomized subjects had preserved postprandial GLP-1 responses in spite of decreased duodenal bile delivery, suggesting that gallbladder emptying is not a prerequisite for GLP-1 release. Cholecystectomized patients demonstrated a slight deterioration of postprandial glycemic control, probably because of metabolic changes unrelated to incretin secretion.

Citing Articles

The effect of cholecystectomy for symptomatic gall stone disease on hepatic steatosis using transabdominal ultrasonography: An observational prospective study.

Dhakaria U, Kumar Bansiwal R, Kavita Khemchand A, Sharma R, Singh M, Kaur N Turk J Surg. 2025; 40(4):320-327.

PMID: 39980651 PMC: 11831990. DOI: 10.47717/turkjsurg.2024.6593.


Cholecystectomy and blood lipid/glucose traits: insights from a population-based cross-sectional and Mendelian randomization study.

Wang Y, Yin Y Am J Transl Res. 2024; 16(11):6655-6667.

PMID: 39678547 PMC: 11645607. DOI: 10.62347/ZFAP9562.


Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients: A Cross-Sectional Study.

Sezer S, Demirci S, Kara M Turk J Gastroenterol. 2024; .

PMID: 39632671 PMC: 11900042. DOI: 10.5152/tjg.2024.24337.


Strong association between sarcopenia and visceral fat in the long term after cholecystectomy: A cross-sectional study using the ISarcoPRM algorithm.

Sezer S, Demirci S, Kara O, Kara M Medicine (Baltimore). 2024; 103(44):e40355.

PMID: 39496063 PMC: 11537645. DOI: 10.1097/MD.0000000000040355.


Diagnosis and treatment of post-cholecystectomy diarrhoea.

Huang R, Huang W, Xiao X, Ma L, Gu H, Yang G World J Gastrointest Surg. 2023; 15(11):2398-2405.

PMID: 38111762 PMC: 10725554. DOI: 10.4240/wjgs.v15.i11.2398.